05/09/2024
7:00 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:17 AM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:59 PM | Corbus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/22/2024
4:05 PM | Corbus Pharmaceuticals (Filer)
| Form PRE 14A | |
03/20/2024
11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
|
03/20/2024
4:07 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
03/20/2024
4:10 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K/A | |
03/20/2024
4:13 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:52 PM | Corbus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/12/2024
4:19 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2024
7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:34 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:13 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
3:45 PM | Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
2:19 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:26 PM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:47 PM | Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
| Form SC 13G | |
02/05/2024
7:12 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
7:55 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K/A | |
02/01/2024
4:27 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:09 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/31/2024
8:16 AM | Corbus Pharmaceuticals (Filer)
| Form S-3MEF | |
01/30/2024
7:40 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/30/2024
7:41 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
5:07 PM | Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:56 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:18 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/30/2024
3:23 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:40 PM | Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/29/2024
6:30 AM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
01/29/2024
6:31 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
7:45 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:25 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:57 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
8:23 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:21 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
8:05 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:44 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
06/13/2023
11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2023
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
06/12/2023
3:53 PM | Corbus Pharmaceuticals (Filer)
| Form S-3/A | |
05/31/2023
8:05 PM | Corbus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2023
3:32 PM | Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:33 PM | Altmeyer Anne (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:17 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:20 PM | Ben Yong (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:22 PM | Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:24 PM | Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:01 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
